Zev A. Wainberg, MD

Professor of Medicine
Department of Gastrointestinal Medical Oncology, David Geffen School of Medicine at UCLA
Los Angeles, California, United States

Presentation(s):

• 90: Pathological complete response to FLOT chemotherapy with or without durvalumab in resectable gastric and gastroesophageal junction cancer: subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study

  Friday, March 22, 2024
  10:42am – 10:52am ET